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Varying Vaccination Rates Among Patients Seeking Care 
for Acute Respiratory Illness: A Systematic Review and 
Meta-analysis
Fadi Shehadeh,1 Ioannis M. Zacharioudakis,2 Markos Kalligeros,1 Evangelia K. Mylona,1 Tanka Karki,1 Robertus van Aalst,3,4 Ayman Chit,3,5 and  
Eleftherios Mylonakis1
1Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA, 2Division of Infectious Diseases and Immunology, Department of Medicine, NYU 
School of Medicine, New York, New York, USA, 3Vaccine Epidemiology and Modelling, Sanofi Pasteur, Swiftwater, Pennsylvania, USA, 4Faculty of Medical Sciences, University of Groningen, 
Groningen, the Netherlands, and 5Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
Background. Complications following influenza infection are a major cause of morbidity and mortality, and the Centers for Disease 
Control Advisory Committee on Immunization Practices recommends universal annual vaccination. However, vaccination rates have re-
mained significantly lower than the Department of Health and Human Services goal. The aim of this work was to assess the vaccination 
rate among patients who present to health care providers with influenza-like illness and identify groups with lower vaccination rates.
Methods. We performed a systematic search of the PubMed and EMBASE databases with a time frame of January 1, 2010, to 
March 1, 2019 and focused on the vaccination rate among patients seeking care for acute respiratory illness in the United States. 
A random effects meta-analysis was performed to estimate the pooled seasonal influenza vaccination rate, and we used a time trend 
analysis to identify differences in annual vaccination over time.
Results. The overall pooled influenza vaccination rate was 48.61% (whites: 50.87%; blacks: 36.05%; Hispanics: 41.45%). There 
was no significant difference among gender groups (men: 46.43%; women: 50.11%). Interestingly, the vaccination rate varied by age 
group and was significantly higher among adults aged >65 (78.04%) and significantly lower among children 9–17 years old (36.45%). 
Finally, we found a significant upward time trend in the overall influenza vaccination rate among whites (coef. = .0107; P = .027).
Conclusions. In conclusion, because of the significantly lower influenza vaccination rates in black and Hispanic communities, societal 
initiatives and community outreach programs should focus on these populations and on children and adolescents aged 9–17 years.
Keywords.  acute respiratory illness; influenza; meta-analysis; systematic review; vaccination.
Influenza infections are a major cause of morbidity and mor-
tality. The Centers for Disease Control and Prevention (CDC) 
has estimated that during the 2017–2018 season, there were 48.8 
million influenza infections that resulted in 22.7 million am-
bulatory health care visits, 959 000 hospitalizations, and 79 400 
deaths [1]. Vaccination is widely considered to be the most 
cost-effective strategy against influenza infection [2]. Following 
the influenza A(H1N1)pdm09 pandemic, the CDC Advisory 
Committee on Immunization Practices (ACIP) expanded the 
existing guidelines and recommended universal annual vacci-
nation in adults and children older than 6 months of age [3]. 
The CDC estimates that in the 2017–2018 season in the United 
States, the vaccination rate was 37.1% for adults [4] and 57.9% 
for children 6 months to 18 years old [5]. However, vaccination 
rates have remained significantly lower than the Department of 
Health and Human Services goal, which has been set at 80% for 
healthy adults and 90% for high-risk adults and elderly individ-
uals [6].
Given the expanded recommendations, population-wide 
assessments of vaccination rate and effectiveness have be-
come important [7]. To estimate the vaccination rate for the 
US population, the CDC analyzes data from the Behavioral 
Risk Factor Surveillance System (BRFSS), a state-based pro-
gram that uses telephone surveys to collect information 
on health conditions of randomly selected individuals [8]. 
Estimates following the influenza A(H1N1)pdm09 pan-
demic ranged from a nadir of 37.1% in 2017–2018 to a peak 
of 43.6% in 2014–2015 [4]. Although this approach is likely 
to give an accurate estimate of the vaccination rate of the 
total US population, it might be less sensitive in reflecting 
the compliance of individuals in contact with the health care 
system [9]. Moreover, patients with comorbidities are at high 
risk for complications and are more likely to seek health 
care during a respiratory illness, making this population of 
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particular interest regarding influenza vaccine uptake [10]. 
In this systematic review, we aim to assess the vaccination 
rate among patients who present to health care providers 
with influenza-like illness and identify subgroups with lower 
vaccination rates.
METHODS
We performed a systematic search of the PubMed and 
EMBASE databases from the implementation of the 2010 
guidelines to March 1, 2019, to identify all studies reporting 
influenza vaccination status among patients seeking care for 
acute respiratory illness. We used the following search terms: 
(influenza OR flu) AND (vaccine OR vaccination) AND 
(respiratory illness OR respiratory infection). Titles and ab-
stracts were screened independently by 2 authors (M.K., F.S.), 
and all relevant studies were accessed in full text. References 
of the studies that were eligible for inclusion were also re-
viewed. As vaccination data and guidelines vary, only data 
from the Unites States were analyzed. This systematic review 
and meta-analysis was conducted according to the Meta-
analysis of Observational Studies in Epidemiology (MOOSE) 
guidelines (Supplementary Table 1) [11].
Study Selection and Outcomes of Interest
Studies were considered eligible and included in our study if 
they reported extractable data on the rate of influenza vaccina-
tion among patients with medically attended acute respiratory 
illness in the United States starting in the 2011–2012 season. 
Studies that did not provide data on influenza vaccination, 
grouped by race, gender, and age, and studies reporting only 
summary data from multiple influenza seasons were excluded. 
The primary outcome of interest was the cumulative annual in-
fluenza vaccination rate of patients seeking care for acute respi-
ratory illness. Subgroup estimates for age, gender, and race were 
examined. As a secondary outcome of interest, we performed a 
time trend analysis to identify differences in annual vaccination 
over time.
Data Extraction and Quality Assessment
Two authors (M.K. and F.S.) independently screened and evalu-
ated eligible articles. Data from the eligible studies were ex-
tracted by F.S. and T.K. Discrepancies were resolved by a third 
reviewer (M.K.) and consensus. The following information was 
extracted from each included study: influenza season, total 
number of vaccinated and unvaccinated subjects, number of 
vaccinated and unvaccinated subjects per race, number of vac-
cinated and unvaccinated subjects per gender, and number of 
vaccinated and unvaccinated subjects per age group.
The quality of the eligible studies was assessed independ-
ently by 2 reviewers (F.S., M.K.) using the National Institutes of 
Health Quality Assessment Tool for Observational Cohort and 
Cross-Sectional Studies [12].
Data Synthesis and Analysis
We performed a random effects meta-analysis to estimate 
the pooled seasonal influenza vaccination rates, grouped 
by gender, age, and race, and their 95% confidence inter-
vals using the DerSimonian and Laird approach [13]. The 
Freeman Tukey double arcsine transformation was utilized to 
stabilize the variances [14]. A random effects approach was 
chosen because we assumed that the effects were heteroge-
neous due to differences in the study settings and the param-
eters affecting vaccination each year. Heterogeneity between 
studies and subgroups was assessed using the I2 statistic [14], 
and the Egger’s test was used to check for publication bias and 
small study effects.
A metaregression analysis was performed to model time 
trends using the first year of each influenza season as a contin-
uous variable. Plots with prediction confidence intervals were 
produced to display and interpret the results of the time trend 
analysis. Stata, version 15.1 (Stata Corporation, College Station, 
TX, USA), was used for the statistical analysis. The significance 
threshold was set at .05.
RESULTS
Our systematic search yielded 1716 nonduplicate citations 
to evaluate. After title and abstract screening, 57 studies were 
identified as eligible for full-text review. Of these studies, 9 
fulfilled our inclusion criteria and were included in our meta-
analysis (Table  1). The detailed review process is shown in 
Supplementary Figure 1. The included studies provided data 
from 46 462 patients and included data from the 2011–2012 
through the 2018–2019 flu seasons, published from 2014 
to 2019.
All included studies were prospective and multicenter. Eight 
studies included data from the US Flu Vaccine Effectiveness 
Network sites in MI, PA, TX, WA, WI [7, 15–17, 19, 21, 22]. 
One study included data from sites in NC, TN, TX, WI [18]. 
All the studies included visits to outpatient clinics only. 
Patients were enrolled if they presented with acute respira-
tory illness and cough in 7 studies [15–17, 19, 21, 22], acute 
respiratory illness and fever in 1 study [18], and acute respi-
ratory illness and cough or fever in 1 study [7]. Vaccination 
status was ascertained from medical records, vaccine regis-
tries, and self-report (Table 1). No study was excluded due to 
quality concerns.
The proportion of vaccinated subjects seeking care for acute 
respiratory illness varied from 44.59% to 54.98% (Figure  1), 
and the overall pooled influenza vaccination rate was 48.61% 
(95% CI, 46.66%–50.56%). Egger’s test for publication bias de-
tected no evidence of small-study effects (bias, 5.72; P = .413). 
The I2 statistic found considerable heterogeneity between the 
studies (I2 = 94.3%; P < .001). When subgrouped by race, the 
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95% CI, 48.81%–52.94%), compared with blacks (36.05%; 95% 
CI, 33.20%–38.90%) and Hispanics (41.45%; 95% CI, 38.89%–
44.02%) (Figure 2).
Subgrouped by gender, the influenza vaccination rate pooled 
estimate varied, but the difference did not reach statistical sig-
nificance and was 46.43% (95% CI, 44.37%–48.50%) for men 
Table 1. Study Characteristics
Study Season Subjects, No. Age, Male, % Setting
Vaccination Docu-
mentation ARI Definition States 
McLean et al., 2015 [15] 2012–2013 6452 ≥6 mo, 41% Outpatient 
clinics
MR, VR, SR ARI and cough MI, PA, TX, 
WA, WI
Ohmit et al., 2014 [7] 2011–2012 4771 ≥6 mo, 51% Outpatient 
clinics
MR, VR ARI and cough or 
fever
MI, PA, TX, 
WA, WI
Gaglani et al., 2016 [16] 2013–2014 5637 ≥6 mo, 42% Outpatient 
clinics
MR, VR, SR ARI and cough MI, PA, TX, 
WA, WI
Zimmerman et al., 2016 [17] 2014–2015 9311 ≥6 mo, 42% Outpatient 
clinics
MR, VR, SR ARI and cough MI, PA, TX, 
WA, WI
McLean et al., 2017 [18] 2014–2015 1511 2–17 y, 50% Outpatient 
clinics
MR, VR ARI and fever NC, TN, TX, WI
Flannery et al., 2018 [19] 2017–2018  
interim
4562 ≥6 mo, 41% Outpatient 
clinics
MR, VR, SR ARI and cough MI, PA, TX, 
WA, WI
Rolfes et al., 2019 [20] 2017–2018 8436 ≥6 mo, 41% Outpatient 
clinics
MR, VR, SR ARI and cough MI, PA, TX, 
WA, WI
Flannery et al., 2018 [21] 2016–2017 7083 ≥6 mo, 42% Outpatient 
clinics
MR, VR, SR ARI and cough MI, PA, TX, 
WA, WI
Doyle et al., 2019 [22] 2018–2019 3254 ≥6 mo, 41% Outpatient 
clinics
MR, VR, SR ARI and cough MI, PA, TX, 
WA, WI
Abbreviations: ARI, acute respiratory illness; MR, medical records; SR, self-report; VR, vaccine registries. 
Study
Ohmit et al., 2014
McLean et al., 2015
Gaglani et al., 2016
Zimmerman et al., 2016
McLean et al., 2017
Flannery et al., 2018
Rolfes et al., 2019
Doyle et al., 2019
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and 50.11% (95% CI, 47.95%–52.28%) for women (Figure 3). 
When subgrouped by age, the vaccination rate varied by age 
group and was significantly higher in the elderly population 
and significantly lower in children 9 to 17 years old, compared 
with adults 18 to 64 years old and children 6 months to 8 years 
old (Figure 4). In particular, the influenza vaccination rate was 
49.48% (95% CI, 46.52%–52.44%) for children 6  months to 
8 years old, 36.45% (95% CI, 34.54%–38.35%) for children and 
adolescents 9 to 17 years old, 44.30% (95% CI, 41.83%–46.76%) 
for adults 18 to 64  years old, and 78.04% (95% CI, 75.63%–
80.45%) for adults older than 65.
A metaregression analysis was performed to evaluate the time 
trend of influenza vaccination rate, yielding a significant upward 
trend in the overall influenza vaccination rate (coef.  =  .0097; 
P = .030), as shown in Figure 5A. When subgrouping for race, 
the vaccination rate of white populations followed a signifi-
cant upward trend (coef.  =  .0107; P = .027) and a slight up-
ward trend for black populations that did not reach significance 
(coef. = .0120; P = .057), while remaining significantly different 
for all flu seasons throughout the years studied (Figure 5B). The 
time trend analysis of the vaccination rate of Hispanics did not 
show a significant trend (P = .853).
When subgrouping by gender, time trend analysis yielded 
a significant upward trend for vaccination of women 
(coef. = .0113; P = .013) but did not show a significant trend for 
men (P = .210), and the trends were not statistically different, as 
evidenced by the overlap between their confidence intervals for 
all the flu seasons studied (Figure 5C).
Finally, when subgrouping by age (Figure  5D), time trend 
analysis yielded a slight upward trend for the 4 age groups 
Study
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examined. The trend was significant for adults 18 to 64 years old 
(coef. = .0107; P = .034) but did not reach statistical significance 
for children 6 months to 8 years old (coef. =  .0024; P = .749), 
children and adolescents 9 to 17  years old (coef.  =  .0039; 
P = .429), or adults older than 65 (coef. = .0999; P = .71).
DISCUSSION
We systematically assessed the vaccination rate among indi-
viduals who presented to an outpatient clinic seeking medical 
care for acute respiratory illness after the expanded recom-
mendations for universal immunization in adults and children 
older than 6 months of age. We found a low cumulative vac-
cination rate of 48.61% among medically attended patients 
with acute respiratory illness. Although a significant upward 
trend over time was observed for white populations, there was 
no time trend observed for black or Hispanic populations and 
vaccination coverage remained low. Furthermore, there were 
significant differences among demographic groups, with a sig-
nificantly higher vaccination rate in elderly patients aged >65, 
compared with children and young adults, as well as among 
white individuals compared with blacks and Hispanics.
The cumulative vaccination rate of almost 50% that we found 
among all patients who presented for an ambulatory health 
care visit for acute respiratory illness on or after the 2011–2012 
season is higher than the CDC overall estimates for the same 
time period, which range from a nadir of 37.1% in 2017–2018 
[4] to a peak of 43.6% in 2014–2015 [23]. The observed higher 
vaccination compliance among the patient subgroup that pre-
sented for evaluation to the health care system could be sec-
ondary to the overrepresentation of patients who were at higher 
risk of developing influenza-related complications in our anal-
ysis [10]. Differences in sampling methods could also have con-
tributed to the higher vaccination rate observed in our analysis.
Study
%
ES (95% CI) Weight
Female
Mele
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The CDC analyzes data from the Behavioral Risk Factor 
Surveillance System, which is a state-based telephone survey 
that has been collecting information on health conditions and 
risk behaviors since 1984 [8]. As response to the telephone sur-
veys is voluntary, selection bias may have been introduced from 
a high nonresponse rate in BRFSS surveys, which was >50% 
for the 2017–2018 season [24]. Indeed, a study that compared 
the BRFSS national estimates to the National Health Interview 
Survey (NHIS), which is conducted by the National Center 
for Health Statistics of the Centers for Disease Control and 
Prevention through a personal household interview, showed 
that BRFSS estimates for influenza immunization were 2.3% 
lower than the NHIS estimates [25]. Also, unlike studies in-
cluded in the present analysis, the majority of which verified 
self-reporting of influenza vaccination status with medical 
record data, BRFSS vaccination rates are based on patient re-
call. Studies have estimated that while the sensitivity of self-
reporting is high, there is low specificity [26] and therefore 
BRFSS data might underestimate the influenza vaccination rate.
Unlike CDC estimates that the influenza vaccination rate has 
remained stable over the last 10 years, we detected a significant 
upward trend over time. This could again be secondary to the 
facts that the patient population of our study is more likely to 
have come in contact with the health care system and the inten-
sified efforts to increase vaccination compliance in this patient 
subgroup over time. On the other hand, based on the NHIS 
survey in 2017, almost 40% of adults aged 18–44 years reported 
that they had not had contact with a health care provider in 
the last ≥6 months [27]. More importantly, based on a Kaiser 
Family Foundation analysis of the BRFSS 2015–2017 Survey 
6 mo-8 y
Study ES (95% CI)
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Results, 28% of men and 17% of women do not have a primary 
care provider [28]. Taken together with the absence of societal 
initiatives and community outreach to increase vaccine uptake 
[29], surveys on the vaccination compliance of the general pop-
ulation might not be able to detect coverage increases in high-
risk patient subgroups.
Despite the upward trend in our analysis, vaccination rates 
remain low overall. Identifying specific factors that play a role in 
an individual’s decision to receive vaccination is an important 
step toward tailored interventions. Two previous literature re-
views that included >500 studies examined the potential factors 
behind vaccine hesitancy and found that factors such as low dis-
ease risk perception, high perceived risk of vaccine side effects, 
negative past experience, personal attitudes, lack of knowledge, 
and perceived behavioral control may negatively impact influ-
enza vaccine uptake among individuals [30, 31]. Furthermore, 
vaccine uptake has been associated with socioeconomic factors 
and education level [32]. In general, the reasons behind vaccine 
hesitancy can be summarized by the 4C model: Complacency, 
lack of Convenience, lack of Confidence, and Calculation (ie, 
vaccination risks outweigh potential benefits) [33]. On the 
other hand, the feeling of social benefit, a history of previous 
vaccination, the presence of social pressure, a direct recommen-
dation from medical personnel, and interaction with the health 
care system may play a positive role toward vaccine uptake [31]. 
Finally, although the impact of the few existing strategies to 
address vaccine hesitancy is not well established to date, strat-
egies that have multiple components, are dialogue-based, and 
address specific patients’ concerns or doubts tend to perform 
better [31, 34].
In agreement with BRFSS data [4] and data from Medicare 
beneficiaries [35], we observed racial disparities, with whites 
having a higher vaccination rate than Hispanics and blacks. 
The above observation is likely multifactorial and might be par-
tially explained by differences in socioeconomic status and ac-
cess to care [35, 36]. In addition, ethnic minorities might be 
more prone to missing opportunities to vaccinate during med-
ical visits [37]. Of note, while we observed an increase in vac-
cination rate among white populations, it is worrisome that the 
vaccination rate among black and Hispanic populations has re-
mained relatively stable and low. Interestingly, when Chen et al. 
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ethnic groups, they found that Hispanics were more likely to 
report access and cost as vaccination barriers, while black in-
dividuals were more likely to raise issues of mistrust against 
influenza vaccine. In this regard, public policies should be tai-
lored to address specific minority barriers, and future studies 
should examine initiatives to increase vaccine uptake in these 
populations.
The limitations of this study include that the published studies 
are not representative of the entire US population and some 
states are not represented in the studies included in our analysis, 
while certain medical sites are overrepresented. Furthermore, 
data on some of the subgroups were missing in some studies, 
while there were sites in the included studies that did not verify 
immunization status by medical records.
CONCLUSIONS
We examined the vaccination rate among individuals who 
sought care for acute respiratory illness in the United States, 
and almost half were vaccinated. While significantly lower 
than the goal of 80% to 90% for 2020, the calculated vacci-
nation rate was higher and with an increasing trend, com-
pared with that reported by nationwide surveys. However, 
racial and age disparities were detected, with lower influ-
enza vaccination rates among black and Hispanic popula-
tions and among children and adolescents aged 9–17 years. 
The analysis identifies subgroups with lower immunization 
compliance that should be targeted by societal initiatives and 
community outreach programs.
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the posted materials are not copyedited and are the sole responsibility 
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